Skip to main content

Next Generation Health Technology Assessment to support patient-centred, societally oriented, real-time decision-making on access and reimbursement for health technologies throughout Europe

Objective

HTx will create a framework for next generation Health Technology Assessment (HTA) that supports patient-centred, societally oriented, and real-time decision-making for integrated healthcare throughout Europe. HTx will focus on therapeutic areas with high unmet need for which HTA information has to be provided on complex and personalised combinations of health technologies.

Based on a select number of relevant case studies, HTx will enhance methods for integrating evidence from RCTs and real-world data (RWD). HTx will also augment statistical and econometric methods for generating robust estimates of effectiveness and cost-effectiveness in order to support relevant HTA decision-making for these complex and personalised combinations of health technologies.

HTx will also contribute to improving methods to support personalised treatment advice fitted for sharing with patients and their physicians. This includes the development of statistical and econometric approaches and artificial intelligence/machine learning methods for forecasting treatment effects in specific groups of patients.

Simultaneously, in close collaboration with the European Network for HTA (EUnetHTA), HTx will improve synergies between regulatory agencies, HTA bodies and clinical guideline developers. This will include the translation of HTx methods into already existing European guidelines, most prominently those developed by EUnetHTA. HTx will also support initial efforts to discuss reimbursement and funding models that facilitate controlled access to and the pricing of these complex health technologies.

Finally, we will evaluate the transferability of HTx results into all EU Member Countries especially in Central and Eastern European (CEE) Countries and promote the dissemination of HTx results to the different European stakeholders with a special focus on the patient community.

Call for proposal

H2020-SC1-2018-Single-Stage-RTD
See other projects for this call

Funding Scheme

RIA - Research and Innovation action

Coordinator

UNIVERSITEIT UTRECHT
Address
Heidelberglaan 8
3584 CS Utrecht
Netherlands
Activity type
Higher or Secondary Education Establishments
EU contribution
€ 1 352 135

Participants (14)

KOBENHAVNS UNIVERSITET
Denmark
EU contribution
€ 228 125
Address
Norregade 10
1165 Kobenhavn
Activity type
Higher or Secondary Education Establishments
OULUN YLIOPISTO
Finland
EU contribution
€ 726 500
Address
Pentti Kaiteran Katu 1
90014 Oulu
Activity type
Higher or Secondary Education Establishments
UNIVERSITY OF YORK
United Kingdom
EU contribution
€ 984 602,50
Address
Heslington
YO10 5DD York North Yorkshire
Activity type
Higher or Secondary Education Establishments
MEDICAL UNIVERSITY SOFIA
Bulgaria
EU contribution
€ 313 687,50
Address
Acad Iv Evstatiev Geshov St 15
1431 Sofia
Activity type
Higher or Secondary Education Establishments
UNIVERSITAET BERN
Switzerland
EU contribution
€ 749 062,50
Address
Hochschulstrasse 6
3012 Bern
Activity type
Higher or Secondary Education Establishments
UNIVERSIDAD POLITECNICA DE MADRID
Spain
EU contribution
€ 382 100
Address
Calle Ramiro De Maeztu 7 Edificio Rectorado
28040 Madrid
Activity type
Higher or Secondary Education Establishments
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL
Belgium
EU contribution
€ 871 250
Address
Avenue E. Mounier 83
1200 Brussels
Activity type
Research Organisations
TANDVARDS-OCH LAKEMEDELSFORMANSVERKET
Sweden
EU contribution
€ 324 000
Address
Fleminggatan 7
10422 Stockholm
Activity type
Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
ZORGINSTITUUT NEDERLAND
Netherlands
EU contribution
€ 484 450
Address
Eekholt 4
1112XH Diemen
Activity type
Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE
United Kingdom
EU contribution
€ 808 250
Address
Level 1A City Tower Piccadilly Plaza
M1 4BT Manchester
Activity type
Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
SYREON KUTATO INTEZET KORLATOLT FELELOSSEGU TARSASAG
Hungary
EU contribution
€ 676 912,50
Address
Mexikoi Ut 65/A
1142 Budapest
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL
Spain
EU contribution
€ 728 937,50
Address
Calle Velazquez 94 Planta 1
28006 Madrid
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
EURORDIS - EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION
France
EU contribution
€ 625 907,50
Address
Rue Didot 96
75014 Paris
Activity type
Other
UNIVERSITEIT MAASTRICHT
Netherlands
EU contribution
€ 384 855
Address
Minderbroedersberg 4-6
6200 MD Maastricht
Activity type
Higher or Secondary Education Establishments